Induced pluripotent stem cells and their potential for basic and clinical sciences

Current Cardiology Reviews

Volumn 9, Issue 1, 2013, Pages 63-72

  Ye, Lei ^a   Swingen, Cory ^a   Zhang, Jianyi ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b University of Minnesota   (United States)

Author keywords

Cellular therapy; Disease model; Embryonic stem cells; Induced pluripotent stem cells; Reprogramm

Indexed keywords

KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

CELL DIFFERENTIATION; CELL MATURATION; CELL STRAIN HEK293; CELL THERAPY; DISEASE MODEL; DOPAMINERGIC NERVE CELL; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; FIBROBLAST; HEART MUSCLE CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LIVER CELL; MUSCLE CELL; MYOBLAST; NERVE CELL; NEURAL STEM CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER; SOMATIC CELL;

EID: 84875820966     PISSN: 1573403X     EISSN: 18756557     Source Type: Journal    
DOI: 10.2174/157340313805076278     Document Type: Review

References (83)

1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-76.
2. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-72.
3. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917-20.
4. Nakagawa M, Koyanagi M, Tanabe K, et al. Generation of induced pluripotent stem cells without myc from mouse and human fibroblasts. Nat Biotechnol 2008; 26: 101-6.
5. Shi Y, Desponts C, Do JT, Hahm HS, Scholer HR, Ding S. Induction of pluripotent stem cells from mouse embryonic fibroblasts by oct4 and klf4 with small-molecule compounds. Cell Stem Cell 2008; 3: 568-74.
6. Huangfu D, Maehr R, Guo W, et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 2008; 26: 795-7.
7. Huangfu D, Osafune K, Maehr R, et al. Induction of pluripotent stem cells from primary human fibroblasts with only oct4 and sox2. Nat Biotechnol 2008; 26: 1269-75.
8. Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent es-cell-like state. Nature 2007; 448: 318-24.
9. Meissner A, Wernig M, Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 2007; 25: 1177-81.
10. Okita K, Ichisaka T, Yamanaka S. Generation of germlinecompetent induced pluripotent stem cells. Nature 2007; 448: 313-7.
11. Kunisato A, Wakatsuki M, Kodama Y, Shinba H, Ishida I, Nagao K. Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells. Stem Cells Develop 2010; 19: 229-38.
12. Hanna J, Markoulaki S, Schorderet P, et al. Direct reprogramming of terminally differentiated mature b lymphocytes to pluripotency. Cell 2008; 133: 250-64.
13. Ye Z, Zhan H, Mali P, et al. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 2009; 114: 5473-80.
14. Ahmed RP, Haider HK, Buccini S, Li L, Jiang S, Ashraf M. Reprogramming of skeletal myoblasts for induction of pluripotency for tumor-free cardiomyogenesis in the infarcted heart. Cir Res 2011; 109: 60-70.
15. Aoi T, Yae K, Nakagawa M, et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 2008; 321: 699-702.
16. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 2008; 322: 945-9.
17. Shimada H, Hashimoto Y, Nakada A, Shigeno K, Nakamura T. Accelerated generation of human induced pluripotent stem cells with retroviral transduction and chemical inhibitors under physiological hypoxia. Biochem Biophys Res Commun 2012; 417: 659-64.
18. Montserrat N, de Onate L, Garreta E, et al. Generation of feeder free pig induced pluripotent stem cells without pou5f1. Cell Transplant 2011.
19. Kim JB, Zaehres H, Wu G, et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 2008; 454: 646-50.
20. Tsai SY, Bouwman BA, Ang YS, et al. Single transcription factor reprogramming of hair follicle dermal papilla cells to induced pluripotent stem cells. Stem Cells 2011; 29: 964-71.
21. Narsinh KH, Jia F, Robbins RC, Kay MA, Longaker MT, Wu JC. Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors. Nat Protocol 2011; 6: 78-88.
22. Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on sendai virus, an rna virus that does not integrate into the host genome. Proceedings of the Japan Academy. Series B, Phys Biol Sci 2009; 85: 348-62.
23. Maekawa M, Yamaguchi K, Nakamura T, et al. Direct reprogramming of somatic cells is promoted by maternal transcription factor glis1. Nature 2011; 474: 225-9.
24. Warren L, Manos PD, Ahfeldt T, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mrna. Cell Stem Cell 2010; 7: 618-30.
25. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. Lmo2-associated clonal t cell proliferation in two patients after gene therapy for scid-x1. Science 2003; 302: 415-9.
26. Hotta A, Ellis J. Retroviral vector silencing during ips cell induction: An epigenetic beacon that signals distinct pluripotent states. J Cell Biochem 2008; 105: 940-8.
27. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008; 322: 949-53.
28. Gonzalez F, Barragan Monasterio M, Tiscornia G, et al. Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc Nat Acad Sci USA 2009; 106: 8918-22.
29. Yu J, Hu K, Smuga-Otto K, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009; 324: 797-801.
30. Zhou H, Wu S, Joo JY, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009; 4: 381-4.
31. Kim D, Kim CH, Moon JI, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009; 4: 472-6.
32. Kim K, Doi A, Wen B, et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010; 467: 285-90.
33. Bar-Nur O, Russ HA, Efrat S, Benvenisty N. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell 2011; 9: 17-23.
34. Stadtfeld M, Brennand K, Hochedlinger K. Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Curr Biol: CB. 2008; 18: 890-4.
35. Sugii S, Kida Y, Berggren WT, Evans RM. Feeder-dependent and feeder-independent ips cell derivation from human and mouse adipose stem cells. Nat Prot 2011; 6: 346-58.
36. Anchan RM, Quaas P, Gerami-Naini B, et al. Amniocytes can serve a dual function as a source of ips cells and feeder layers. Human Mol Genet 2011; 20: 962-74.
37. Sun N, Panetta NJ, Gupta DM, et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Nat Acad Sci USA 2009; 106: 15720-5.
38. Loh YH, Agarwal S, Park IH, et al. Generation of induced pluripotent stem cells from human blood. Blood 2009; 113: 5476-9.
39. Takenaka C, Nishishita N, Takada N, Jakt LM, Kawamata S. Effective generation of ips cells from cd34+ cord blood cells by inhibition of p53. Exp Hematol 2010; 38: 154-62.
40. Yan X, Qin H, Qu C, et al. Ips cells reprogrammed from human mesenchymal-like stem/progenitor cells of dental tissue origin. Stem Cell Develop 2010; 19: 469-80.
41. Panopoulos AD, Ruiz S, Yi F, Herrerias A, Batchelder EM, Izpisua Belmonte JC. Rapid and highly efficient generation of induced pluripotent stem cells from human umbilical vein endothelial cells. PloS one 2011; 6: e19743.
42. Miyoshi K, Tsuji D, Kudoh K, et al. Generation of human induced pluripotent stem cells from oral mucosa. J Biosci Bioeng 2010; 110: 345-50.
43. Luo J, Suhr ST, Chang EA, et al. Generation of leukemia inhibitory factor and basic fibroblast growth factor-dependent induced pluripotent stem cells from canine adult somatic cells. Stem Cell Develop 2011; 20: 1669-78.
44. Nagy K, Sung HK, Zhang P, et al. Induced pluripotent stem cell lines derived from equine fibroblasts. Stem Cell Rev 2011; 7: 693-702.
45. Liu H, Zhu F, Yong J, et al. Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell 2008; 3: 587-90.
46. Okahara-Narita J, Umeda R, Nakamura S, Mori T, Noce T, Torii R. Induction of pluripotent stem cells from fetal and adult cynomolgus monkey fibroblasts using four human transcription factors. Primates; J Primatol 2011.
47. Montserrat N, Bahima EG, Batlle L, et al. Generation of pig ips cells: A model for cell therapy. J Cardiovasc Translat Res 2011; 4: 121-130.
48. West FD, Terlouw SL, Kwon DJ, et al. Porcine induced pluripotent stem cells produce chimeric offspring. Stem Cell Develop 2010; 19: 1211-20.
49. Ezashi T, Telugu BP, Alexenko AP, Sachdev S, Sinha S, Roberts RM. Derivation of induced pluripotent stem cells from pig somatic cells. Proc Nat Acad Sci USA 2009; 106: 10993-8.
50. Honda A, Hirose M, Hatori M, et al. Generation of induced pluripotent stem cells in rabbits: Potential experimental models for human regenerative medicine. J Biol Chem 2010; 285: 31362-9.
51. Hamanaka S, Yamaguchi T, Kobayashi T, et al. Generation of germline-competent rat induced pluripotent stem cells. PloS one 2011; 6: e22008.
52. Li Y, Cang M, Lee AS, Zhang K, Liu D. Reprogramming of sheep fibroblasts into pluripotency under a drug-inducible expression of mouse-derived defined factors. PloS one 2011; 6: e15947.
53. Bao L, He L, Chen J, et al. Reprogramming of ovine adult fibroblasts to pluripotency via drug-inducible expression of defined factors. Cell Res 2011; 21: 600-8.
54. Miura K, Okada Y, Aoi T, et al. Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol 2009; 27: 743-5.
55. Tsuji O, Miura K, Okada Y, et al. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Nat Acad Sci USA 2010; 107: 12704-9.
56. Mauritz C, Schwanke K, Reppel M, et al. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 2008; 118: 507-17.
57. Zhang J, Wilson GF, Soerens AG, et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Cir Res 2009; 104: e30-41.
58. Rufaihah AJ, Huang NF, Jame S, et al. Endothelial cells derived from human ipscs increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. Arterioscl Thromb Vasc Biol 2011; 31: e72-79.
59. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 2009; 120: 408-16.
60. Dubois NC, Craft AM, Sharma P, et al. Sirpa is a specific cellsurface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol 2011; 29: 1011-8.
61. Elliott DA, Braam SR, Koutsis K, et al. Nkx2-5egfp/w hescs for isolation of human cardiac progenitors and cardiomyocytes. Nat Methods 2011; 8: 1037-40.
62. Tateishi K, He J, Taranova O, Liang G, D'Alessio AC, Zhang Y. Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J Biol Chem 2008; 283: 31601-7.
63. Zhang D, Jiang W, Liu M, et al. Highly efficient differentiation of human es cells and ips cells into mature pancreatic insulinproducing cells. Cell Res 2009; 19: 429-38.
64. Alipio Z, Liao W, Roemer EJ, et al. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (ips)-derived pancreatic beta-like cells. Proc Nat Acad Sci USA 2010; 107: 13426-31.
65. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L. Highly efficient neural conversion of human es and ips cells by dual inhibition of smad signaling. Nat Biotechnol 2009; 27: 275-80.
66. Swistowski A, Peng J, Liu Q, et al. Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells 2010; 28: 1893-904.
67. Lee G, Chambers SM, Tomishima MJ, Studer L. Derivation of neural crest cells from human pluripotent stem cells. Nat Protocols 2010; 5: 688-701.
68. Wernig M, Zhao JP, Pruszak J, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with parkinson's disease. Proc Nat Acad Sci USA 2008; 105: 5856-61.
69. Hargus G, Cooper O, Deleidi M, et al. Differentiated parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in parkinsonian rats. Proc Nat Acad Sci USA 2010; 107: 15921-6.
70. Ebert AD, Yu J, Rose FF, Jr., et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009; 457: 277-80.
71. Moretti A, Bellin M, Welling A, et al. Patient-specific induced pluripotent stem-cell models for long-qt syndrome. New Eng J Med 2010; 363: 1397-409.
72. Itzhaki I, Maizels L, Huber I, et al. Modelling the long qt syndrome with induced pluripotent stem cells. Nature 2011; 471: 225-9.
73. Lahti AL, Kujala VJ, Chapman H, et al. Model for long qt syndrome type 2 using human ips cells demonstrates arrhythmogenic characteristics in cell culture. DMM 2011.
74. Matsa E, Rajamohan D, Dick E, et al. Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long qt syndrome type 2 mutation. Euro Heart J 2011; 32: 952-62.
75. Malan D, Friedrichs S, Fleischmann BK, Sasse P. Cardiomyocytes obtained from induced pluripotent stem cells with long-qt syndrome 3 recapitulate typical disease-specific features in vitro. Cir Res 2011; 109: 841-7.
76. Raya A, Rodriguez-Piza I, Guenechea G, et al. Disease-corrected haematopoietic progenitors from fanconi anaemia induced pluripotent stem cells. Nature 2009; 460: 53-9.
77. Maehr R, Chen S, Snitow M, et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Nat Acad Sci USA 2009; 106: 15768-73.
78. Dimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with als can be differentiated into motor neurons. Science 2008; 321: 1218-21.
79. Zhang N, An MC, Montoro D, Ellerby LM. Characterization of human huntington's disease cell model from induced pluripotent stem cells. PLoS Curr 2010; 2: RRN1193.
80. Lee G, Papapetrou EP, Kim H, et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific ipscs. Nature 2009; 461:402-6.
81. Carvajal-Vergara X, Sevilla A, D'Souza SL, et al. Patient-specific induced pluripotent stem-cell-derived models of leopard syndrome. Nature 2010; 465: 808-12.
82. Yazawa M, Hsueh B, Jia X, et al. Using induced pluripotent stem cells to investigate cardiac phenotypes in timothy syndrome. Nature 2011; 471: 230-4.
83. Pasca SP, Portmann T, Voineagu I, et al. Using ipsc-derived neurons to uncover cellular phenotypes associated with timothy syndrome. Nat Med 2011; 17: 1657-62.